Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
Clinical trial NCT01663727 · COMPLETED
Trial details
- NCT number
- NCT01663727
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-27
- Primary completion
- 2014-11-30
- Enrollment
- 481
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.